CEFPODOXIME 200mg. IP

A broad-spectrum antibiotic that has good antimicrobial activity against aerobic gram-positive and gram-negative bacteria. (Arijit Ghosh, 2012) Exerts higher cure rates (95.6%) compared with other oral third-generation cephalosporins. (Arijit Ghosh, 2012) Has potent antibacterial activity against the major bacterial pathogens involved in lower respiratory tract infections. (Geddes, 1991) A safe and useful agent in the therapy of skin and soft tissue infections. (K J Tack, 1991) Demonstrates a higher eradication rate of pathogens (97.6%) in the skin and soft tissue infections. (K J Tack, 1991) A valuable addition to the antibacterial available for the treatment of infections of the lower respiratory tract. (A M Geddes, 1991) A better-tolerated medicine that is associated with better compliance than penicillin-based regimens. (J A Balfour P. B., 1996) An efficacious molecule as parenterally administered ceftriaxone for the treatment of bronchopneumonia in hospitalized individuals. (J E Frampton, 1992) Shows greater clinical efficacy [97.2%] than co-amoxidav [94.7%] in the treatment of acute exacerbations of chronic bronchitis. (P. Periti, 1990)